Link to this page
Thyroid Cancer Ontology
Last uploaded:
July 2, 2020
Jump to:
| Preferred Name | Axitinib | |
| Synonyms |
|
|
| Definitions |
An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect. |
|
| ID |
http://www.semanticweb.org/hx-jta/ontologies/thyroid_cancer_ontology#Axitinib |
|
| ChineseLabel |
阿西替尼
|
|
| Definition |
An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.
|
|
| NCI_code |
C38718
|
|
| prefLabel |
Axitinib
|
|
| synonyms |
AXITINIB Inlyta AG013736 Axitinib axitinib N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide AG-013736
|
|
| URL |
https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38718 |
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping